Expression of TGF-β1 protein and mRNA and the effect on the tissue remodeling in laryngeal carcinomas

Anticancer Research

Volumn 19, Issue 5 B, 1999, Pages 4265-4272

  Hagedorn, H ^a   Sauer, U ^b   Schleicher, E ^c   Nerlich, A ^b  

^a LUDWIG MAXIMILIANS UNIVERSITY   (Germany)

^b UNIVERSITY OF MUNICH   (Germany)

^c UNIVERSITY OF TÜBINGEN   (Germany)

Author keywords

Interstitial collagen types; Laryngeal carcinoma; Tenascin; TGF 1 mRNA; TGF 1 protein; Tumor cell proliferation

Indexed keywords

ANTIBODY; COLLAGEN TYPE 3; COLLAGEN TYPE 5; COLLAGEN TYPE 6; MESSENGER RNA; MONOCLONAL ANTIBODY KI 67; TENASCIN; TRANSFORMING GROWTH FACTOR BETA1;

ARTICLE; BASAL CELL; CELL PROLIFERATION; CLINICAL ARTICLE; CONTROLLED STUDY; EXTRACELLULAR MATRIX; HUMAN; HUMAN CELL; IMMUNOHISTOCHEMISTRY; IN SITU HYBRIDIZATION; LARYNX CARCINOMA; LARYNX MUCOSA; MOLECULAR CLONING; PRIORITY JOURNAL; PROTEIN SYNTHESIS INHIBITION; SQUAMOUS CELL CARCINOMA; STROMA CELL; TISSUE REGENERATION;

EID: 0032795113     PISSN: 02507005     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (22)

1. Assoian RK, Komoriya A, Meyer CA, Miller DM, Sporn MB: Transforming growth factor-beta in human platelets. Identification of a major storage site, purification and characterization. J Biol Chem 258(11): 7155-7160, 1983.
2. Ceol M, Nerlich A, Baggio B, Anglani F, Sauer U, Schleicher E, Gambaro G: Increased glomerular α 1 (IV) collagen expression and deposition in long-term diabetic rats is prevented by chronic glycosaminoglycan treatment. Lab Invest 74: 484-495, 1996.
3. Damjanov I, Damjanov N, Knowles BB, Engvall E: Origin of laminin in the extracellular matrix of human tumor xenografts in nude mice. Virchows Arch B49: 45-52, 1985.
4. Eckel H, Hake R, Betten Th, Streppel M, Thiele J: Evaluation of monoclonal antibodies PC 10, MIB 1, p53, and Leu M1 in early stage squamous cell carcinomas of the larynx. Head and neck cancer: Advances in Basic Research 343-350, 1996.
5. Eisma RJ, Spiro JD, Biberstein SE, Linquist R, Kreutzer D: Decreased expression of TGF-β receptors on Head and Neck squamous cell carcinoma tumor cells. Am J Surg 101: 641-645, 1996.
6. Frenette GP, Carey TE, Varani J, Schwartz DR, Fligel SEG, Ruddon RW, Peters BR: Biosynthesis and secretion of laminin and laminin-associated glycoproteins by nonmalignant and malignant human keratinocytes: Comparison of cell lines from primary and secondary tumors in the same patient. Cancer Res 48: 5193-5202, 1988.
7. Garrigue-Antar L, Munoz-Antonia T, Antonia S, Gesmonde J, Vellucci VF, Reiss M: Missense mutations of the transforming growth factor β type II receptor in human head and neck squamous cell carcinoma cells. Cancer Res 15: 3982-3987, 1995.
8. Hagedorn H, Tübel J, Wiest I, Nerlich A: In situ apoptotic and proliferation index in laryngeal squamous cell carcinomas. Anal Cell Pathol 19: 177-184, 1998.
9. Hoosein NM, McKnight MK, Levine AE, Mulder KM, Childress FF, Brattain DE: Differential sensitivity of subclasses of human colon carcinoma cell lines to the growth inhibitory effects of transforming growth factor -β1. Exp Cell Res 181: 442-453, 1989.
10. Hsu SM, Raine L, Fanger A: A comparative study of the peroxidase-antiperoxidase method and an avidin-biotin complex method for studying polypeptide hormones with radio immunoassay antibodies. Am J Clin Pathol 75: 734-739, 1981.
11. Kane CJM, Knapp AM, Mansbridge JN, Hanawalt PC: Transforming growth factors β1 localization in normal and psoriatic epidermal keratinocytes in situ. J Cell Physiol 144: 144-150, 1990.
12. Kataoka R, Sherlock J, Lanier SM: Signaling events initiated by transforming growth factor-beta 1 that require Gi alpha 1. J Biol Chem 268 (26): 19851-19857, 1993.
13. Kleinsasser O: Tumoren des Larynx und des Hypopharynx. Georg Thieme Verlag Stuttgart, New York 1987.
14. Kim TA, Cutry AF, Kinniburgh AJ, Wenner CE: Transforming growth factor beta1-induced delay of cell cycle progression and its association with growth-related gene expression in mouse fibroblasts. Cancer Letters 71(1-3): 125-132, 1993.
15. Lawrence DA: Transforming growth factor-β: a general rewiev. Eur Cytokine Netw 7: 363-374, 1996.
16. Lu SH, Zhang WC, Akiyama Y, Nomizu T, Yuasa Y: Genomic structure of the transforming growth factor β type II receptor gene and ist mutations in hereditary nonpolyposis colorectal cancers. Cancer Res 56: 4595-4598, 1993.
17. Moses HL, Branum EL, Proper JA, Robinson RA: Transforming growth factor production by chemically transformed cells. Cancer Res 41(7): 2842-2848, 1981.
18. Nerlich AG, Wiest I, Wagner E, Sauer U, Schleicher ED: Gene expression and protein deposition of major basement membrane components and TGF-β1 in human breast cancer. Anticancer Res 17: 4443-4450, 1997.
19. Olofsson J, Golusiunski W: Prognostic factors in squamous cell neoplasia of the upper-aero-digestive tract head and neck cancer. Advances in Basic Research 511-520, 1996.
20. Pennybacker M, Hermann B: Transforming growth factor-beta (TGF-β) induced phosphorylation of myristoylated alanine rich C kinase substrate (MARCKS) protein in ovarian granulosa cells is modulated by follicle stimulating hormone (FSH). Res Commun Chem Pathol Pharmacol 78: 359-366, 1992.
21. Soini Y, Pääkkö P, Autio-Harmainen H. Genes of laminin B1 chain, α1(IV) chain of type IV collagen and 72-kd type IV collagenase are mainly expressed by the stromal cells of lung carcinomas. Am J Pathol 142: 1622-1630, 1993.
22. Vivien D, Petitfrere E, Martiny L, Sartelet H, Galera P, Haye B, Pujol JP: IPG (inositolphosphate glycan) as a cellular signal for TGF-beta 1 modulation of chondrocyte cell cycle. J Cell Physiol 155(3): 437-444, 1993.